SHMARQL

budesonide/formoterol

<http://www.wikidata.org/entity/Q863389>

combination formulation containing budesonide and formoterol used in the management of asthma and chronic obstructive pulmonary disease
rdfs:label
"budesonide/formoterol"@en
skos:altLabel
"budesonide / formoterol"@en
schema:description
"combination formulation containing budesonide and formoterol used in the management of asthma and chronic obstructive pulmonary disease"@en
schema:dateModified "2026-08-01T11:13:51+00:00"^^xsd:dateTime
schema:version 2525627791
wikibase:identifiers 21
wikibase:sitelinks 16
wikibase:statements 43
p:P11089 wd:statement/Q863389-49085D73-19B4-401F-B051-343B8C7D95C4
p:P11143 wd:statement/Q863389-9BF0F75E-3F35-49DB-A18E-6CF9885BDFCC
p:P2017 wd:statement/Q863389-e129037c-4d19-b7cb-701d-e9d9f8116866
p:P2067 wd:statement/Q863389-9828C6ED-71C1-4EDB-874A-F362A24E837F
p:P2175 wd:statement/Q863389-3D7441F3-E346-42A0-956A-FF3B0DE0FB71
wd:statement/Q863389-3E3AC948-DD5B-42B3-935A-29B2280A5B51
wd:statement/Q863389-583D7234-AEF6-4373-92E9-863443521599
wd:statement/Q863389-72FE84E4-1028-4601-83A0-1A0656293D24
wd:statement/Q863389-E42AAF77-1632-431F-A2C2-5907A855A028
p:P231 wd:statement/Q863389-7fd83866-4da6-1b54-f6fe-766cd9e2d1e8
p:P233 wd:statement/Q863389-c88825eb-4634-df62-d6a9-5afecc2d17a1
p:P234 wd:statement/Q863389-A94D23EC-C72E-4BD7-AE0B-DACE8CDF6F62
p:P235 wd:statement/Q863389-959fdc86-4118-c171-cb84-82a9705f0692
p:P267 wd:statement/Q863389-B8D2122F-F727-45FD-BD98-1AC10A07D4EB
p:P274 wd:statement/Q863389-13B24268-4089-4F38-88E6-73030A7F9692
p:P2877 wd:statement/Q863389-10696E9E-6827-4A98-8D2D-CA198CCA6298
p:P31 wd:statement/Q863389-4EC98732-EF75-45EE-8394-233F64600DCF
wd:statement/Q863389-ce0acfb0-48f8-df51-1783-b4cae0962afe
p:P3117 wd:statement/Q863389-2A0C81A3-3C03-4C23-81C4-9A8AFC9AE46E
p:P3345 wd:statement/Q863389-f7f7690f-41fa-ab00-51dd-2dca863b84fe
p:P3489 wd:statement/Q863389-972F464C-CBA6-4B8D-BA7F-2FD723B95D5E
p:P366 wd:statement/Q863389-2FCC387F-A8FE-4BBA-9742-3DE23DADBD11
wd:statement/Q863389-5C166935-9B14-4021-89F5-13F240E0F505
p:P3780 wd:statement/Q863389-0017D418-8F09-4AD2-A051-14544FA8A14A
wd:statement/Q863389-7469FDA8-9D22-4D38-B8FB-0B1D7FBAFEFD
wd:statement/Q863389-AB29904B-AEAA-4555-841B-1CAE7BA96894
wd:statement/Q863389-BE82BEE6-5572-481B-8994-61D24F32EE28
wd:statement/Q863389-D94CF9E2-F0B5-4509-9B12-54A5F5136777
wd:statement/Q863389-FC167441-F3DB-4853-87D4-9A0F926B2ABE
p:P486 wd:statement/Q863389-A316EED7-97C3-4098-B4DC-74AC97C3938D
p:P527 wd:statement/Q863389-0DD4DAB1-91D1-443C-9C34-64009F4D5C5B
wd:statement/Q863389-e6d7acee-41c6-bcee-1446-f6f090e3af36
p:P6366 wd:statement/Q863389-E03770C0-171F-40D6-82C0-509516CF2B17
p:P646 wd:statement/Q863389-7B010CB6-DC20-420E-90F6-4B2F7F20171B
p:P661 wd:statement/Q863389-e7dcd2bd-4883-900c-abaf-ce34607e3b47
p:P662 wd:statement/Q863389-866f4075-4d32-59e0-c0c2-3a84c7fc6cb4
p:P672 wd:statement/Q863389-3861b8de-4d77-391e-68bd-f91da3af1cac
wd:statement/Q863389-71fa01a2-40ab-2ab4-ce3b-5e40c1d4c9aa
wd:statement/Q863389-9eacc770-41f5-7e8a-b125-de8b688ade7f
wd:statement/Q863389-c2adaef0-45ca-b428-2a3a-99e3193b848e
p:P8494 wd:statement/Q863389-E58B0051-F7DE-4720-838C-DACC64A02A65
p:P9635 wd:statement/Q863389-5D75116E-E76A-43D1-8216-93EBBF7A8F88
wd:statement/Q863389-CA2695C7-3DBB-44A9-91E0-BEED8CCDD97F
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/D000069502>
p:direct-normalized/P6366 <https://makg.org/entity/2777450039>
p:direct-normalized/P661 <http://rdf.chemspider.com/57530667>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56841116>
p:direct-normalized/P672 <http://id.nlm.nih.gov/mesh/D02.033.100.291.425.250>
<http://id.nlm.nih.gov/mesh/D02.092.063.291.425.250>
<http://id.nlm.nih.gov/mesh/D04.210.500.745.745.654.105.500>
<http://id.nlm.nih.gov/mesh/D26.310.348>
wdt:P11089 "49964008"
wdt:P11143 "Budesonide/formoterol"
wdt:P2017 "CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C.C[C@@H](CC1=CC=C(C=C1)OC)NC[C@H](C2=CC(=C(C=C2)O)NC=O)O"
wdt:P2067 774.9404^^xsd:decimal
wdt:P2175 pneumonia
ulcerative colitis
microscopic colitis
respiratory disease
lung disease
wdt:P231 "150693-37-1"
wdt:P233 "CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C.CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O"
wdt:P234 "InChI=1S/C25H34O6.C19H24N2O4/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26;1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3;3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t16-,17-,18-,20+,21?,22+,23-,24-,25+;13-,19+/m00/s1"
wdt:P235 "PJFHZKIDENOSJB-JIVDDGRNSA-N"
wdt:P267 "R03AK07"
wdt:P274 "C₄₄H₅₈N₂O₁₀"
wdt:P2877 "29373342"
wdt:P31 mixture
chemical substance
wdt:P3117 "DTXSID80872449"
wdt:P3345 "389132"
wdt:P3489 US pregnancy category C
wdt:P366 medication
WHO essential medicines
wdt:P3780 Biresp Spiromax
Budesonide/formoterol Teva
Budesonide/formoterol Teva Pharma B.v.
Duoresp Spiromax
Vylaer Spiromax
Symbicort
wdt:P486 "D000069502"
wdt:P527 budesonide
formoterol
wdt:P6366 "2777450039"
wdt:P646 "/m/04ntjd"
wdt:P661 "57530667"
wdt:P662 "56841116"
wdt:P672 "D02.033.100.291.425.250"
"D02.092.063.291.425.250"
"D04.210.500.745.745.654.105.500"
"D26.310.348"
wdt:P8494 "DTXCID90820097"
wdt:P9635 "251"
"252"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata